Loading
CA
Combigene AB Stock: price and insider trades · Sweden
ISIN SE0006504593SE·
No insider purchase over the last 90 days. The latest was filed 01 Apr 2021.
Combigene AB: what insiders have been doing
Every trade that managers of Combigene AB disclose to Finansinspektionen is tracked on this page. Nothing new has been filed by managers of Combigene AB in twelve months, the latest record being from 1 April 2021.
Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€24,895
2 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 1 April 2021
Declarations2 total
222,222 shares@ SEK 0.45100.0% of flowBTA (betald tecknad aktie)ISIN SE0006504593FI:A001R829-2
Canonical exit: 29 Jun 2021 (T+90)
344,480 shares@ SEK 0.45100.0% of flowBTA (betald tecknad aktie)ISIN SE0006504593FI:A001R747-2
Canonical exit: 27 Jun 2021 (T+90)
2 of 2 declarations
About Combigene AB
Combigene AB is a biopharmaceutical company focused on developing treatments for genetic and neurological diseases. It is listed on the XSTO market.
